Pluristem Granted Key Cell Patents in Asia, Russia, Mexico, and Israel

Pluristem Granted Key Cell Patents in Asia, Russia, Mexico, and Israel

Company fortifies IP assets in important markets HAIFA, ISRAEL / CRWEPRESSRELEASE / June 1, 2015 / Pluristem Therapeutics Inc . (Nasdaq: PSTI) (TASE: PLTR), a leading developer of placenta-based cell therapy products, today announced it has been gra...

Close